Chronic myeloid leukaemia trials in Greece

3 of 4 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 12 November 2026. Ask the study team whether a trial fits you.

• Phase 4Taking people
  Asciminib Roll-over Study

  Where

  Athens, Thessaloniki

  Age

  7 years to 100 years

  People

  347 worldwide

  Run by

  Novartis Pharmaceuticals

  See details and how to joinNCT04877522 · EU 2023-507557-16-00
• Phase 1Enrolling by invitation
  A Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring

  Where

  Athens

  Age

  18 years and over

  People

  120 worldwide

  Run by

  Janssen Research & Development, LLC

  See details and how to joinNCT06788509 · EU 2024-515457-21-00
• Phase 2Taking people
  Study to evaluate the safety and efficacy of asciminib in pediatric participants with chronic myeloid leukemia.

  Where

  Athens

  Age

  Up to 17 years

  People

  16 worldwide

  Run by

  Novartis Pharma AG

  See details and how to join2025-522138-29-00